Replies to post #237879 on Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

Nope. Read the damn article.

“GC4419 has completed phase 1 and 2 trials and is poised to enter phase 3 this year. If approved, it could be used to ward off SOM and its side effects not just in patients with head and neck cancers, but in those with other types of cancer.”

[Echo20]

Groton88

Closer than you think.

Echo20